In this issue of Blood, Sanders and coworkers define the pathophysiology of types 1, 2, and 3 von Willebrand disease (VWD) in the Willebrand in the Netherlands (WiN) study by using the ratios of von Willebrand factor propeptide (VWFpp) or factor VIII activity to VWF antigen.
Haberichter, S. L. (2015, May 7). VWF propeptide in defining VWD subtypes. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-03-629832